Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
US Cataract Pharmaceuticals Evolve in Drug Delivery
US cataract surgeons showed a preference for incremental improvement in drug delivery over revolutionary change in the first full year for three new corticosteroid products to manage inflammation a...
Katena Buys ASICO, Building on Roster of Recent Acquisitions
Katena Products announced April 14 that it had purchased fellow ophthalmic surgical instrument maker ASICO, of Westmont, Illinois. The companies said ASICO’s product portfolio comprises more than 1...
Alimera Licenses its Steroid Implant to Ocumension for Asian Markets, Receives $20 Million
Alimera Sciences announced April 14 that China’s Ocumension Therapeutics had paid $10 million up front to license Alimera’s 0.19 mg fluocinolone acetonide intravitreal implant, which Alimera market...
Bausch + Lomb Dry Eye Candidate Licensed from Novaliq Meets All Endpoints in Phase III Trial
Bausch + Lomb, a division of Canada’s Bausch Health, and Germany’s Novaliq announced April 13 statistically significant topline data from the first Phase III trial of NOV03 (perfluorohexyloctane) f...
AAO, NEI, Others Urge Ophthalmic Equipment Manufacturers to Standardize Digital Imaging
The American Academy of Ophthalmology published a report April 5 urging ophthalmic imaging device manufacturers to standardize image formats to comply with the Digital Imaging and Communications in...
J&J Vision Surgical Gains US Clearance for Veritas Next-Generation Phaco System
Johnson & Johnson Vision Surgical gained US FDA 510(k) clearance on March 12 for its Veritas Vision System. The phacoemulsification system is an updated version of the company’s WhiteStar Signature...
Alcon Introduces UV-Filtering Versions of PanOptix, Vivity IOLs in Canada
Alcon announced on April 12 that it had launched in Canada four next-generation IOLs to provide ultraviolet (UV)-filtering hydrophobic protection. The models are the AcrySof IQ PanOptix UV intraocu...
AGTC Licenses X-Linked Retinoschisis Gene Therapy Program to TeamedOn
Applied Genetic Technologies Corporation (AGTC) announced April 13 that it had reached a licensing deal with TeamedOn International to advance a gene therapy candidate to treat X-linked retinoschis...
Apellis Sees Positive Results with Pegcetacoplan at 24 Months in GA
Apellis Pharmaceuticals on April 13 reported 24-month data from its Phase Ib study of pegcetacoplan. The targeted C3 therapy is under investigation as a treatment for bilateral advanced geographic ...
Qlaris Bio Enrolls First Patient in Phase I/II Studies of Glaucoma Candidate
Qlaris Bio announced April 15 that it had enrolled the first patient in the Phase I/II clinical program for QLS-101, an investigational therapy designed to lower intraocular pressure (IOP) by reduc...
Harrow Health Announces Public Offering of $50 Million in Senior Notes
Harrow Health announced April 15 that it has commenced an underwritten registered public offering of $50 million in senior notes due 2026. The company, based in Nashville, Tennessee, said it expect...
Bionic Sight Reports Light Sensitivity in RP Patients Treated with Gene Therapy Candidate
Bionic Sight, of New York, reported March 30 that the first four patients treated with its gene therapy candidate for retinitis pigmentosa were able to detect light and motion, and two could detect...
Past News Stories
US FDA Approves Bausch + Lomb’s ClearVisc Dispersive OVD
Bausch + Lomb announced April 7 that the US FDA had approved its ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. OVDs aid in cataract extraction and intrao...
Chinese Regulators Approve IND for Neurophth’s LHON Gene Therapy Candidate
Neurophth Biotechnology announced April 1 that the China National Medical Products Administration had approved the company’s investigational new drug (IND) application for its gene therapy candidat...
Oxurion Secures Capital Commitment of up to $35.8 Million from Negma Group
Belgium’s Oxurion announced April 6 that it had agreed to a capital commitment of up to €30 million (US $35.8 million) from Negma Group. Negma Group is a growth-focused debt and equity firm based i...
ProQR Raises $103.5 Million After Full Exercise of Underwriters’ Option
Netherlands-based ProQR Therapeutics announced April 5 that it had closed an underwritten public offering of 13,846,154 ordinary shares at $6.50 per share. Underwriters fully exercised their option...
Pixium, Second Sight Merger Deal Falls Apart in Flap over Private Placement
Pixium Vision announced April 3 that the merger deal between it and fellow retinal implant company Second Sight had been scrapped, following a controversial private placement closed by Second Sight...
Horizon Says it Will Resupply Market with Tepezza Beginning in April
Horizon Therapeutics announced March 30 that the US FDA had approved a prior approval supplement (PAS) giving Horizon authorization to manufacture more Tepezza, resulting in an increased number of ...
Zeiss’ $180 Million Innovation Center Opens Near San Francisco
German company Zeiss announced March 31 that it had opened its Zeiss Innovation Center, a newly constructed facility built on 13.5 acres in Dublin, California, near San Francisco. The $180 million ...
Hovione’s Minocycline for Inflamed MGD Shows Promise in Phase II Trial
Hovione announced March 17 that it had completed a Phase II clinical trial of an ophthalmic formulation of minocycline in 270 patients with dry eye caused by meibomian gland dysfunction (MGD). The ...
Tarsus, LianBio Partner on Demodex Blepharitis, MGD Candidate in Greater China
Tarsus Pharmaceuticals, of Irvine, California, announced March 29 that it had formed a partnership with Chinese biotech company LianBio to develop and commercialize Tarsus’ TP-03 in the Greater Chi...
AffaMed Raises More than $170 Million in Series B, Makes Deal to Market SIFI IOLs in Greater China
AffaMed Therapeutics announced March 30 that it had raised more than $170 million in a Series B financing. The oversubscribed round was led by Lake Bleu Capital, with participation by new investors...
ProQR Prices $90 Million Underwritten Public Offering
Netherlands-based ProQR Therapeutics announced March 30 that it had priced an underwritten public offering of 13,846,154 ordinary shares at $6.50 per share. The company has also granted the underwr...
Gyroscope Therapeutics Raises $148 Million in Series C Financing
UK-based gene therapy company Gyroscope Therapeutics announced March 26 that it had raised $148 million in a Series C financing. The round was led by Forbion’s Growth Opportunities Fund and include...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.